thymopoietins - CISMeF

Preferred Label : thymopoietins;

MeSH definition : Two closely related polypeptides (molecular weight 7,000) isolated from the thymus gland. These hormones induce the differentiation of prothymocytes to thymocytes within the thymus. They also cause a delayed impairment of neuromuscular transmission in vivo and are therefore believed to be the agent responsible for myasthenia gravis.;

MeSH synonym : thymins; Thymin; Thymopoietin;

CISMeF synonym : II, thymopoietin; I, thymopoietin;

MeSH hyponym : thymopoietin I; thymopoietin II; TP-49; TP 49;

MeSH annotation : /biosyn /physiol permitted; do not confuse X ref THYMINS with THYMINE; do not confuse entry term THYMINS with THYMINE;

Wikipedia link : https://en.wikipedia.org/wiki/Thymopoietins;

Is substance : O;

Details

Origin ID

D013946;

UMLS CUI

C0040105;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 5-methyluracil [Substance BNPC]
- Lamina-Associated Polypeptide 2, Isoform Alpha [NCIt concept]
- Lamina-Associated Polypeptide 2, Isoforms Beta/Gamma [NCIt concept]
- Thymic neuromuscular function blocking agent (substance) [SNOMED CT concept]
- Thymine [NCIt concept]
- Thymine [FMA entity]
- Thymine [LOINC component]
- Thymine (substance) [SNOMED CT concept]
- Thymopoietin [OMIM gene]
- thymic neuromuscular function blocking agent [SNOMED Notion]
- thymine [SNOMED Notion]
- thymopoietin [HGNC gene]
- thymopoietin [ORDO Gene]
Currated CISMeF NLP mapping
- TMPO Gene Product [NCIt concept]
Record concept(s)
- thymopoietin I [MeSH concept]
- thymopoietin II [MeSH concept]
- thymopoietins [MeSH concept]
Related MeSH Supplementary Concept(s)
- N-acetylsplenopeptin [MeSH Supplementary Concept]
- TMPO protein, human [MeSH Supplementary Concept]
- berlopentin [MeSH Supplementary Concept]
- cardiomyopathy, dilated, 1t [MeSH Supplementary Concept]
- cyclo(arginyl-prolyl-aspartyl-valyl-tyrosyl) [MeSH Supplementary Concept]
- lamina-associated polypeptide 2, zebrafish [MeSH Supplementary Concept]
- splenopentin [MeSH Supplementary Concept]
- splenotritin [MeSH Supplementary Concept]
- thymocartin [MeSH Supplementary Concept]
- thymopoietin (38-45) [MeSH Supplementary Concept]
- thymopoietin II octadecapeptide (32-49) [MeSH Supplementary Concept]
- thymopoietin II, 4-fluoro-Phe(3)- [MeSH Supplementary Concept]
- thymopoietin II, Nal(3)- [MeSH Supplementary Concept]
- thymopoietin III [MeSH Supplementary Concept]
- thymopoietin, cys (28-39)- [MeSH Supplementary Concept]
- thymopoietin-related peptide precursor [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
UMLS correspondences (same concept)
- TMPO Gene Product [NCIt concept]
- Thymic neuromuscular function blocking agent (substance) [SNOMED CT concept]
- thymic neuromuscular function blocking agent [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients